Stock BIOSTAGE INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Analyst Reco. Biostage Inc Nasdaq

Equities

US41690A1060

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Biostage Inc
04-15 Harvard Apparatus Regenerative Technology Inc. announced that it expects to receive $1.482101 million in funding CI
03-28 Harvard Apparatus Regenerative Technology Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. HRGN Stock
  4. Stock
  5. News Biostage Inc
  6. Analyst Reco.